Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys

Abstract Cocaine, which non-selectively blocks the reuptake of the monoamines serotonin, dopamine and norepinephrine, produces weak antinociceptive effects and increases the antinociceptive effects of low- to intermediate-efficacy mu opioid agonists in rhesus monkeys. In the present study, the antinociceptive effects of more selective monoamine reuptake inhibitors administered alone and in combination with mu opioid agonists were evaluated in rhesus monkeys using a warm-water tail-withdrawal assay of thermal nociception. Like cocaine, the selective serotonin reuptake inhibitors clomipramine (0.01–3.2 mg/kg) and fluoxetine (0.1–10 mg/kg) produced weak antinociceptive effects. Pretreatment with the serotonin receptor antagonist mianserin (0.032–0.32 mg/kg) produced rightward and downward shifts in the clomipramine dose-effect curve, suggesting that the effects of clomipramine were mediated by serotonin receptors. Combination of clomipramine with the low efficacy mu agonist nalbuphine or the intermediate efficacy mu agonist morphine produced more antinociception than did the mu agonists alone. Fluoxetine also produced a small leftward shift in the morphine dose-effect curve. The selective norepinephrine reuptake inhibitors nisoxetine (0.1–10 mg/kg) and tomoxetine (0.1–10 mg/kg) and the selective dopamine reuptake inhibitors bupropion (0.032–3.2 mg/kg) and GBR 12909 (0.1–10 mg/kg) did not produce antinociception or increase antinociception induced by nalbuphine or morphine. In fact, GBR 12909 produced dose-dependent allodynia and reduced the maximal antinociceptive effects of morphine. These results suggest that inhibition of serotonin reuptake is sufficient to produce weak antinociceptive effects and enhance the antinociceptive effects of low efficacy mu opioid agonists. These results also suggest that the effects of cocaine on serotonin reuptake may contribute to cocaine’s antinociceptive effects in rhesus monkeys.

[1]  R. Melzack,et al.  The Brompton mixture: effects on pain in cancer patients , 1976 .

[2]  G. Cohen,et al.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.

[3]  J. Leander,et al.  Clonidine analgesia and suppression of operant responding: dissociation of mechanism. , 1981, European journal of pharmacology.

[4]  M. Ossipov,et al.  Augmentation of central and peripheral morphine analgesia by desipramine. , 1982, Archives internationales de pharmacodynamie et de therapie.

[5]  T. Morrow,et al.  Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia , 1989, Brain Research.

[6]  M. Fitzgerald.  Monoamines and descending control of nociception , 1986, Trends in Neurosciences.

[7]  J. Han,et al.  Serotonin receptor subtypes in spinal antinociception in the rat. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  T. Reisine.  Opioid analgesics and antagonists , 1996 .

[9]  H. Takagi,et al.  Evidence for involvement of separate mechanisms in the production of analgesia by electrical stimulation of the nucleus reticularis paragigantocellularis and nucleus raphe magnus in the rat , 1980, Brain Research.

[10]  R. Jacobson,et al.  Enhancement of morphine analgesia by fenfluramine in subjects receiving tailored opioid infusions , 1993, Pain.

[11]  M. Ossipov,et al.  Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoamines , 1988, Neuropharmacology.

[12]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[13]  A. Larson,et al.  Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. , 1977, Life sciences.

[14]  B. Ho,et al.  Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. , 1978, Research communications in chemical pathology and pharmacology.

[15]  R. Foltin,et al.  The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. , 1992, The Journal of pharmacology and experimental therapeutics.

[16]  N. Barbaro,et al.  Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat , 1985, Brain Research.

[17]  J. Fujimoto,et al.  Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice. , 1991, The Journal of pharmacology and experimental therapeutics.

[18]  P. Thut,et al.  Imipramine-fentanyl antinociception in a rabbit tooth pulp model. , 1991, Life sciences.

[19]  A. Eschalier,et al.  Evidence for a central but not a peripheral analgesic effect of clomipramine in rats , 1991, Pain.

[20]  B. Koe.  Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. , 1976, The Journal of pharmacology and experimental therapeutics.

[21]  A I Basbaum,et al.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.

[22]  J. Levine,et al.  Interactions between fluoxetine and opiate analgesia for postoperative dental pain , 1994, Pain.

[23]  J. Levine,et al.  Desipramine enhances opiate postoperative analgesia , 1986, Pain.

[24]  R. Pontani,et al.  Stereospecific potentiation of opiate analgesia by cocaine: predominant role of noradrenaline , 1987, Pain.

[25]  L. Harris,et al.  The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. , 1970, The Journal of pharmacology and experimental therapeutics.

[26]  S. Fleetwood-Walker,et al.  Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. , 1988, The Journal of physiology.

[27]  R. M. Bowker,et al.  Serotonergic projections to the spinal cord from the midbrain in the rat: An immunocytochemical and retrograde transport study , 1981, Neuroscience Letters.

[28]  Reith Me.  Cocaine receptors on monoamine transporters and sodium channels. , 1988 .

[29]  J. Woods,et al.  Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys. , 1993, The Journal of pharmacology and experimental therapeutics.

[30]  B. Shyu,et al.  Spinal antinociception mediated by a cocaine-sensitive dopaminergic supraspinal mechanism , 1994, Brain Research.

[31]  T. Kameyama,et al.  Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol. , 1986, Journal of pharmacobio-dynamics.

[32]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[33]  R. Shank,et al.  Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. , 1995, The Journal of pharmacology and experimental therapeutics.

[34]  K. Bemis,et al.  Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors. , 1985, Life sciences.

[35]  T. Yaksh.  Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing , 1985, Pharmacology Biochemistry and Behavior.

[36]  L. Olson,et al.  A new major projection from locus coeruleus: The main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord , 1977, Brain Research.

[37]  O. Lindvall,et al.  Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat , 1985, Brain Research.

[38]  A. Duttaroy,et al.  Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. , 1992, Life sciences.

[39]  E. Zecca,et al.  Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man , 1990, Pain.

[40]  M. Ossipov,et al.  An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. , 1990, The Journal of pharmacology and experimental therapeutics.

[41]  N. Mello,et al.  Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys. , 1995, The Journal of pharmacology and experimental therapeutics.

[42]  J. Mendelson,et al.  A primate model of polydrug abuse: cocaine and heroin combinations. , 1995, The Journal of pharmacology and experimental therapeutics.

[43]  B. Mount,et al.  Use of the Brompton mixture in treating the chronic pain of malignant disease. , 1976, Canadian Medical Association journal.

[44]  T. Yanagita,et al.  Mode of potentiating action of cocaine in morphine analgesia. , 1988, Japanese journal of pharmacology.

[45]  E. Mecke,et al.  Enhancement of morphine-induced analgesia and attenuation of morphine-induced side-effects by cocaine in rats. , 1992, Pharmacology & toxicology.

[46]  T. Yaksh.  Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray , 1979, Brain Research.

[47]  B. Rounsaville,et al.  A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? , 1987, Archives of general psychiatry.

[48]  M. Ossipov,et al.  Elevation in analgetic effect and plasma levels of morphine by desipramine in rats , 1982, Pain.

[49]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[50]  B. Rounsaville,et al.  Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. , 1986, The American journal of drug and alcohol abuse.

[51]  L. C. Terry,et al.  Dopamine D-1 and D-2 receptor antagonists potentiate analgesic and motor effects of morphine , 1989, Pharmacology Biochemistry and Behavior.